Recent studies have suggested some surprising things (not beaming from the center of our solar system) that might increase your risk for skin cancer. We delved into the research to help you assess whether you should be concerned — or not.
Recent studies have suggested some surprising things (not beaming from the center of our solar system) that might increase your risk for skin cancer. We delved into the research to help you assess whether you should be concerned — or not.
The Skin Cancer Foundation’s Research Grants Program has given young physicians and investigators a special boost for studies that served as stepping stones to major lifesaving breakthroughs.
Each year, we award several grants to dermatology residents, fellows and young faculty to fund research and clinical studies related to skin cancer.
With the recent FDA approval of the drug nivolumab (Opdivo®, previously approved for stage IV melanoma) as a treatment for stage III melanoma, we have reached the next important phase in the immunotherapy revolution. It is a revolution that most of the world’s top experts believe will one day, very possibly within a decade, turn advanced (stages III and IV) melanoma into a chronic, or even curable, disease rather than a deadly one.
We know some of our loyal readers are medical professionals, skin cancer patients and caregivers. Many of you are as invested in skin cancer-related news and research as we are! Here’s a look back at a few 2017 headlines that got our attention.
English
Chinese (Simplified)
French
German
Italian
Portuguese
Spanish